U.S. market Closed. Opens in 1 hour 49 minutes

RDHL | RedHill Biopharma Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue6.51M61.80M85.76M64.36M6.29M8.36M4.01M101.00K3.00K7.01M12.00K16.00K23.00KN/A
Cost of Revenue3.45M33.34M49.41M36.89M2.26M2.84M2.13MN/AN/A1.05MN/AN/AN/AN/A
Gross Profit3.06M28.46M36.35M27.47M4.03M5.52M1.88M101.00K3.00K5.96M12.00K16.00KN/AN/A
Operating Expenses34.41M71.31M117.49M91.15M47.23M44.85M53.85M30.64M22.00M16.61M10.78M9.06MN/AN/A
Selling, General & Admin30.90M64.03M87.99M74.66M29.81M19.99M20.04M5.40M4.13M4.01M2.68M2.60M2.48M518.00K
Research & Development3.52M7.28M29.50M16.49M17.42M24.86M32.97M25.24M17.77M12.70M8.10M6.46M5.41M736.00K
Other Operating Expenses8.60MN/AN/AN/AN/AN/A845.00KN/A100.00K-100.00KN/AN/AN/AN/A
Operating Income-31.35M-42.84M-81.14M-63.68M-43.20M-39.33M-51.97M-30.54M-22.00M-10.65M-10.77M-9.04M-7.87M-1.73M
Other Expenses / Income55.21M-28.82M-16.61M-12.49M897.00K274.00K6.43M1.17M912.00K-64.00K144.00K-1.29M-7.63M-811.00K
Before Tax Income23.85M-71.67M-97.74M-76.17M-42.30M-38.82M-45.54M-29.37M-21.09M-10.71M-10.63M-10.33M-15.50M-2.54M
Income Tax Expenses-2.00-12.42M16.57M12.84M1.33M727.00KN/AN/AN/AN/AN/AN/AN/AN/A
Net Income23.92M-59.24M-114.31M-89.02M-43.63M-38.82M-45.54M-29.37M-21.09M-10.71M-10.63M-10.33M-15.50M-2.54M
Interest Expenses367.00K41.33M16.57M12.76M438.00K167.00K6.24M1.09M912.00K22.00K14.00K1.48M65.00K876.00K
Basic Shares Outstanding6.48M1.55M1.16M910.69K742.30K570.88K17.52M128.51M110.81M8.66M6.24M5.26M4.81M5.26M
Diluted Shares Outstanding6.48M1.55M1.16M910.69K742.30K570.88K17.52M128.51M110.81M8.72M6.24M5.26M4.81M5.26M
EBITDA-29.37M-34.61M-63.00M-54.67M-40.65M-38.56M-39.22M-28.23M-20.14M-10.66M-10.59M-8.82M-15.42M-1.80M
EBITDA Margin-450.87%-56.00%-73.46%-84.94%-646.21%-461.28%-978.89%-27,953.47%-671,400.00%-152.01%-88,250.00%-55,118.75%-67,056.52%0.00%
EBIT24.28M-30.34M-81.18M-63.41M-41.87M-37.93M-39.30M-28.28M-20.18M-10.69M-10.61M-8.84M-15.44M-1.67M
EBIT Margin372.83%-49.09%-94.66%-98.53%-665.49%-453.66%-980.91%-27,997.03%-672,600.00%-152.40%-88,450.00%-55,268.75%-67,121.74%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙